Immix Biopharma(IMMX) - 2022 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Commission File Number: 001-41159 11400 West Olympic Blvd., Suite 200, Los Angeles, CA 90064 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identification No.) (310) 651-8041 (Registrant's telephone number, including area code) For the transition period from ...